Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting
Chimeric antigen receptor (CAR) T cell therapeutic responses are hampered by limited T cell trafficking, persistence, and durable anti-tumor activity in solid tumor microenvironments. However, these challenges can be largely overcome by relatively unconstrained synthetic engineering strategies, whic...
Saved in:
Published in | bioRxiv : the preprint server for biology |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
07.01.2023
|
Online Access | Get more information |
Cover
Loading…
Abstract | Chimeric antigen receptor (CAR) T cell therapeutic responses are hampered by limited T cell trafficking, persistence, and durable anti-tumor activity in solid tumor microenvironments. However, these challenges can be largely overcome by relatively unconstrained synthetic engineering strategies, which are being harnessed to improve solid tumor CAR T cell therapies. Here, we describe fully optimized CAR T cells targeting tumor-associated glycoprotein-72 (TAG72) for the treatment of solid tumors, identifying the CD28 transmembrane domain upstream of the 4-1BB co-stimulatory domain as a driver of potent anti-tumor activity and IFNγ secretion. These findings have culminated into a phase 1 trial evaluating safety, feasibility, and bioactivity of TAG72-CAR T cells for the treatment of patients with advanced ovarian cancer ( NCT05225363 ). Preclinically, we found that CAR T cell-mediated IFNγ production facilitated by IL-12 signaling was required for tumor cell killing, which was recapitulated by expressing an optimized membrane-bound IL-12 (mbIL12) molecule on CAR T cells. Critically, mbIL12 cell surface expression and downstream signaling was induced and sustained only following CAR T cell activation. CAR T cells with mbIL12 demonstrated improved antigen-dependent T cell proliferation and potent cytotoxicity in recursive tumor cell killing assays
and showed robust
anti-tumor efficacy in human xenograft models of ovarian cancer peritoneal metastasis. Further, locoregional administration of TAG72-CAR T cells with antigen-dependent IL-12 signaling promoted durable anti-tumor responses against both regional and systemic disease in mice and was associated with improved systemic T cell persistence. Our study features a clinically-applicable strategy to improve the overall efficacy of locoregionally-delivered CAR T cells engineered with antigen-dependent immune-modulating cytokines in targeting both regional and systemic disease. |
---|---|
AbstractList | Chimeric antigen receptor (CAR) T cell therapeutic responses are hampered by limited T cell trafficking, persistence, and durable anti-tumor activity in solid tumor microenvironments. However, these challenges can be largely overcome by relatively unconstrained synthetic engineering strategies, which are being harnessed to improve solid tumor CAR T cell therapies. Here, we describe fully optimized CAR T cells targeting tumor-associated glycoprotein-72 (TAG72) for the treatment of solid tumors, identifying the CD28 transmembrane domain upstream of the 4-1BB co-stimulatory domain as a driver of potent anti-tumor activity and IFNγ secretion. These findings have culminated into a phase 1 trial evaluating safety, feasibility, and bioactivity of TAG72-CAR T cells for the treatment of patients with advanced ovarian cancer ( NCT05225363 ). Preclinically, we found that CAR T cell-mediated IFNγ production facilitated by IL-12 signaling was required for tumor cell killing, which was recapitulated by expressing an optimized membrane-bound IL-12 (mbIL12) molecule on CAR T cells. Critically, mbIL12 cell surface expression and downstream signaling was induced and sustained only following CAR T cell activation. CAR T cells with mbIL12 demonstrated improved antigen-dependent T cell proliferation and potent cytotoxicity in recursive tumor cell killing assays
and showed robust
anti-tumor efficacy in human xenograft models of ovarian cancer peritoneal metastasis. Further, locoregional administration of TAG72-CAR T cells with antigen-dependent IL-12 signaling promoted durable anti-tumor responses against both regional and systemic disease in mice and was associated with improved systemic T cell persistence. Our study features a clinically-applicable strategy to improve the overall efficacy of locoregionally-delivered CAR T cells engineered with antigen-dependent immune-modulating cytokines in targeting both regional and systemic disease. |
Author | Jun Lee, Eric Hee Yang, Jason Adkins, Lauren N Woo, Yanghee Cristea, Mihaela Ishihara, Jun Rodriguez-Rodriguez, Lorna Forman, Stephen J Cullen, Cody Park, Anthony K Gumber, Diana Chung-Chang, Wen Murad, John P Martinez, Catalina Dhapola, Gaurav Gittins, Brenna Wang, Leo D Lee, John K Priceman, Saul J Stern, Lawrence A |
Author_xml | – sequence: 1 givenname: Eric Hee surname: Jun Lee fullname: Jun Lee, Eric Hee – sequence: 2 givenname: Cody surname: Cullen fullname: Cullen, Cody – sequence: 3 givenname: John P surname: Murad fullname: Murad, John P – sequence: 4 givenname: Diana surname: Gumber fullname: Gumber, Diana – sequence: 5 givenname: Anthony K surname: Park fullname: Park, Anthony K – sequence: 6 givenname: Jason surname: Yang fullname: Yang, Jason – sequence: 7 givenname: Lawrence A surname: Stern fullname: Stern, Lawrence A – sequence: 8 givenname: Lauren N surname: Adkins fullname: Adkins, Lauren N – sequence: 9 givenname: Gaurav surname: Dhapola fullname: Dhapola, Gaurav – sequence: 10 givenname: Brenna surname: Gittins fullname: Gittins, Brenna – sequence: 11 givenname: Wen surname: Chung-Chang fullname: Chung-Chang, Wen – sequence: 12 givenname: Catalina surname: Martinez fullname: Martinez, Catalina – sequence: 13 givenname: Yanghee surname: Woo fullname: Woo, Yanghee – sequence: 14 givenname: Mihaela surname: Cristea fullname: Cristea, Mihaela – sequence: 15 givenname: Lorna surname: Rodriguez-Rodriguez fullname: Rodriguez-Rodriguez, Lorna – sequence: 16 givenname: Jun surname: Ishihara fullname: Ishihara, Jun – sequence: 17 givenname: John K surname: Lee fullname: Lee, John K – sequence: 18 givenname: Stephen J surname: Forman fullname: Forman, Stephen J – sequence: 19 givenname: Leo D surname: Wang fullname: Wang, Leo D – sequence: 20 givenname: Saul J surname: Priceman fullname: Priceman, Saul J |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36711615$$D View this record in MEDLINE/PubMed |
BookMark | eNqFjj0LwjAQQDMofv8FuT_QoYp1LkVRcJLuNTZnOEguIReH_ns76Oz0lvfgLdWEA-NMzffVsSyr8rBQj5ozWeTCYEQ2yBmut6LcgZBl7YgtEENT36GFHp0TiCn4kFEgoaUwOpADyCAZPfVgSFALQtbJYh7ztZq-tBPcfLlS2_OpbS5FfD89mi4m8joN3W9p91f4ADJVPow |
ContentType | Journal Article |
DBID | NPM |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
ExternalDocumentID | 36711615 |
Genre | Preprint |
GroupedDBID | NPM |
ID | FETCH-pubmed_primary_367116152 |
IngestDate | Tue Jan 31 01:22:43 EST 2023 |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-pubmed_primary_367116152 |
PMID | 36711615 |
ParticipantIDs | pubmed_primary_36711615 |
PublicationCentury | 2000 |
PublicationDate | 2023-Jan-07 |
PublicationDateYYYYMMDD | 2023-01-07 |
PublicationDate_xml | – month: 01 year: 2023 text: 2023-Jan-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | bioRxiv : the preprint server for biology |
PublicationTitleAlternate | bioRxiv |
PublicationYear | 2023 |
Score | 3.7462866 |
Snippet | Chimeric antigen receptor (CAR) T cell therapeutic responses are hampered by limited T cell trafficking, persistence, and durable anti-tumor activity in solid... |
SourceID | pubmed |
SourceType | Index Database |
Title | Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36711615 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LS8NAEMcXqyC9iOL7UebgLUTaJCbtsRS1FlukROit5rGRgCZFo6if3pl9pLVafFxC2IVk6W87O5n9zyxjx3EUY7vDTSF8QoMXmq0Y_-74zRNwz0laTp2ykfsDt3vj9Eano-khiCK7pAhPovdv80r-QxXbkCtlyf6BbPlQbMB75ItXJIzXXzFuZwUV0zT1SbaFcXllNiyDRBnBvcpW6bSHhm9QgP6J1FiIhtNWwZ0SmueqmHMa6c0aQ6rD9ZqmPNcwzYev6YuhhSATKoeZ4isprMsfpewz_RSk7z1nhhL6kLnFJa6cRR2q-i33-_P4bYa6nHFCz1Nmnl2IU0uEdcTJHMwGKixbBCq8WTONI5w8CBa26zXI1_y5d64atu6qsIrXJIs2uO5X2apunvs4EE6Cv87WlHcPbYlqgy3xbJPdfsEEAhOUmCDNADGBDwITaEygMUGRg8YEChOUmLZY7fzM73RNOajxRFYQGevhWttsOcszvsvASixcNoPQdt26Qwq1euByL4jtpBE1bbe1x3YWPGR_Yc8Bq05BHLKVBOc9P0Inqghr4pf7AMnRKRo |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antigen-dependent+IL-12+signaling+in+CAR+T+cells+promotes+regional+to+systemic+disease+targeting&rft.jtitle=bioRxiv+%3A+the+preprint+server+for+biology&rft.au=Jun+Lee%2C+Eric+Hee&rft.au=Cullen%2C+Cody&rft.au=Murad%2C+John+P&rft.au=Gumber%2C+Diana&rft.date=2023-01-07&rft_id=info%3Apmid%2F36711615&rft_id=info%3Apmid%2F36711615&rft.externalDocID=36711615 |